LLY

1,053.38

+2.52%↑

JNJ

213.72

+1.08%↑

ABBV

228.04

+2.05%↑

UNH

338.91

-0.73%↓

AZN

91.04

+1.39%↑

LLY

1,053.38

+2.52%↑

JNJ

213.72

+1.08%↑

ABBV

228.04

+2.05%↑

UNH

338.91

-0.73%↓

AZN

91.04

+1.39%↑

LLY

1,053.38

+2.52%↑

JNJ

213.72

+1.08%↑

ABBV

228.04

+2.05%↑

UNH

338.91

-0.73%↓

AZN

91.04

+1.39%↑

LLY

1,053.38

+2.52%↑

JNJ

213.72

+1.08%↑

ABBV

228.04

+2.05%↑

UNH

338.91

-0.73%↓

AZN

91.04

+1.39%↑

LLY

1,053.38

+2.52%↑

JNJ

213.72

+1.08%↑

ABBV

228.04

+2.05%↑

UNH

338.91

-0.73%↓

AZN

91.04

+1.39%↑

Search

Nektar Therapeutics

Closed

54.72 7.63

Overview

Share price change

24h

Current

Min

54.09

Max

55.41

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.87

Profit margin

-301.289

Employees

61

EBITDA

6.9M

-29M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+78.48% upside

Market Stats

By TradingEconomics

Market Cap

26M

1.2B

Previous open

47.09

Previous close

54.72

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 gru 2025, 22:53 UTC

Acquisitions, Mergers, Takeovers

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13 gru 2025, 00:04 UTC

Acquisitions, Mergers, Takeovers

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14 gru 2025, 23:46 UTC

Market Talk

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14 gru 2025, 23:36 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14 gru 2025, 22:38 UTC

Acquisitions, Mergers, Takeovers

Fortescue to Take Full Control of US$101M Copper Miner Alta

14 gru 2025, 22:02 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14 gru 2025, 22:01 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14 gru 2025, 22:01 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14 gru 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14 gru 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14 gru 2025, 21:59 UTC

Acquisitions, Mergers, Takeovers

Fortescue to Acquire Remaining 64% of Alta Copper

14 gru 2025, 17:00 UTC

Earnings

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14 gru 2025, 08:30 UTC

Acquisitions, Mergers, Takeovers

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13 gru 2025, 16:48 UTC

Acquisitions, Mergers, Takeovers

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 gru 2025, 08:00 UTC

Acquisitions, Mergers, Takeovers

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 gru 2025, 07:00 UTC

Acquisitions, Mergers, Takeovers

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13 gru 2025, 00:24 UTC

Acquisitions, Mergers, Takeovers

Want a Piece Of SpaceX? -- Barrons.com

12 gru 2025, 23:49 UTC

Acquisitions, Mergers, Takeovers

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 gru 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 gru 2025, 22:32 UTC

Earnings

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 gru 2025, 20:45 UTC

Earnings

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 gru 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 gru 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 gru 2025, 19:23 UTC

Earnings

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 gru 2025, 18:35 UTC

Acquisitions, Mergers, Takeovers

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 gru 2025, 18:33 UTC

Acquisitions, Mergers, Takeovers

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 gru 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 gru 2025, 17:49 UTC

Earnings

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 gru 2025, 17:34 UTC

Acquisitions, Mergers, Takeovers

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

78.48% upside

12 Months Forecast

Average 97.63 USD  78.48%

High 121 USD

Low 30 USD

Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

7

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat